- Home
- DUETU vs CYCCP Comparison
DUETU vs CYCCP Comparison
Compare DUETU & CYCCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUETU
- CYCCP
- Stock Information
- Founded
- DUETU N/A
- CYCCP N/A
- Country
- DUETU
- CYCCP United States
- Employees
- DUETU N/A
- CYCCP 12
- Industry
- DUETU
- CYCCP Biotechnology: Pharmaceutical Preparations
- Sector
- DUETU
- CYCCP Health Care
- Exchange
- DUETU NYSE
- CYCCP Nasdaq
- Market Cap
- DUETU N/A
- CYCCP N/A
- IPO Year
- DUETU N/A
- CYCCP N/A
- Fundamental
- Price
- DUETU $11.30
- CYCCP $7.04
- Analyst Decision
- DUETU
- CYCCP
- Analyst Count
- DUETU 0
- CYCCP 0
- Target Price
- DUETU N/A
- CYCCP N/A
- AVG Volume (30 Days)
- DUETU N/A
- CYCCP N/A
- Earning Date
- DUETU N/A
- CYCCP N/A
- Dividend Yield
- DUETU N/A
- CYCCP N/A
- EPS Growth
- DUETU N/A
- CYCCP N/A
- EPS
- DUETU N/A
- CYCCP N/A
- Revenue
- DUETU N/A
- CYCCP N/A
- Revenue This Year
- DUETU N/A
- CYCCP N/A
- Revenue Next Year
- DUETU N/A
- CYCCP N/A
- P/E Ratio
- DUETU N/A
- CYCCP N/A
- Revenue Growth
- DUETU N/A
- CYCCP N/A
- 52 Week Low
- DUETU N/A
- CYCCP N/A
- 52 Week High
- DUETU N/A
- CYCCP N/A
- Technical
- Relative Strength Index (RSI)
- DUETU 53.35
- CYCCP 43.05
- Support Level
- DUETU N/A
- CYCCP $6.75
- Resistance Level
- DUETU N/A
- CYCCP $8.00
- Average True Range (ATR)
- DUETU 0.00
- CYCCP 0.41
- MACD
- DUETU -0.00
- CYCCP 0.07
- Stochastic Oscillator
- DUETU 0.00
- CYCCP 50.77
About DUETU DUET ACQUISITION CORP
DUET Acquisition Corp is a blank check company.
About CYCCP Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.